1. Centers for Medicare & Medicaid Services. Medicare Provider Utilization and Payment Data: Part D Prescriber Data CY 2015. Drug Summary Table: “Part D Drug National Summary table, CY2015, Microsoft Excel (.xlsx)”. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/PartD2015.html. Accessed September 11, 2017.
2. Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D;Yusuf;Am J Kidney Dis,2014
3. US Renal Data System 2016 annual data report: epidemiology of kidney disease in the United States;Saran;Am J Kidney Dis,2017
4. A review of phosphate binders in chronic kidney disease: incremental progress or just higher costs?;St Peter;Drugs,2017
5. US Food and Drug Administration. Guidance for industry: diabetes mellitus - evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes. www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm071627.pdf. Accessed September 11, 2017.